Stay updated on T-Guard vs Ruxolitinib in Acute GvHD Clinical Trial
Sign up to get notified when there's something new on the T-Guard vs Ruxolitinib in Acute GvHD Clinical Trial page.

Latest updates to the T-Guard vs Ruxolitinib in Acute GvHD Clinical Trial page
- Check4 days agoChange DetectedA new revision entry v3.3.4 was added to the record history, while v3.3.3 was removed. This update does not alter study data or visible page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page now displays Revision: v3.3.3, and the HHS Vulnerability Disclosure and Revision: v3.3.2 were removed from the footer.SummaryDifference0.2%

- Check54 days agoChange DetectedMinor revision label updated from v3.2.0 to v3.3.2 in the record history, a technical metadata change that does not affect study data or page functionality; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check61 days agoChange DetectedThe funding/operating status notice banner was removed from the page. This does not affect the study record history or data presented on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check75 days agoChange Detected- A new version was posted on 2024-08-22 with updates to Study Status, Recruitment Status, and Outcome Measures.SummaryDifference0.1%

- Check104 days agoChange DetectedCore content updated to v3.2.0 with a government-operating-status notice and a removal of the previous v3.1.0 marker.SummaryDifference11%

Stay in the know with updates to T-Guard vs Ruxolitinib in Acute GvHD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the T-Guard vs Ruxolitinib in Acute GvHD Clinical Trial page.